{
    "2020-06-19": [
        [
            {
                "time": "",
                "original_text": "甘李药业：重组胰岛素类似物产业化生产 取得进口替代市场先机",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "重组胰岛素",
                        "类似物",
                        "产业化",
                        "进口替代",
                        "市场先机"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "甘李药业：中国胰岛素技术研发的引领者",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "胰岛素技术",
                        "研发",
                        "引领者"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}